Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease

Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease

Francisco A. Ferreira, Bruno D. Benites, Fernando F. Costa, Simone Gilli, Sara T. Olalla-Saad

ARTIGO

Inglês

Disturbances in the physiological regulation of erythropoietin (EPO) in patients with sickle cell disease (SCD) may contribute to worsening anaemia and increased transfusion requirements, but the use of recombinant EPO in this group of patients is controversial. The objective of this study was to...

fechado

Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease

Francisco A. Ferreira, Bruno D. Benites, Fernando F. Costa, Simone Gilli, Sara T. Olalla-Saad


										

Recombinant erythropoietin as alternative to red cell transfusion in sickle cell disease

Francisco A. Ferreira, Bruno D. Benites, Fernando F. Costa, Simone Gilli, Sara T. Olalla-Saad

    Fontes

    Vox sanguinis

    Vol. 114, no. 2 (Feb., 2019), p. 178-181